Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2021-06-01 Sale |
2021-06-03 5:48 pm |
Stoke Therapeutics Inc. | STOK | Nash Huw M. COO & CBO |
575 | $39.43 | $22,669 | 124,822 (Direct) |
View |
| 2020-12-28 Sale |
2021-03-04 5:00 pm |
Stoke Therapeutics Inc. | STOK | Liau Gene EVP Research & Preclinical Dev |
5,344 | $62.93 | $336,297 | 233,094 (Direct) |
View |
| 2021-03-01 Sale |
2021-03-03 5:10 pm |
Stoke Therapeutics Inc. | STOK | LEVIN ARTHUR A Director |
12,500 | $60.79 | $759,841 | 26,743 (Indirect Direct) |
View |
| 2021-02-22 Sale |
2021-02-24 5:15 pm |
Stoke Therapeutics Inc. | STOK | Tulipano Stephen J CFO |
30,000 | $58.86 | $1,765,896 | 365,596 (Direct) |
View |
| 2021-02-19 Sale |
2021-02-23 5:28 pm |
Stoke Therapeutics Inc. | STOK | TZIANABOS ARTHUR Director |
10,000 | $60.67 | $606,652 | 13,447 (Direct) |
View |
| 2021-01-04 Sale |
2021-01-06 5:26 pm |
Stoke Therapeutics Inc. | STOK | Nash Huw M. COO & CBO |
5,732 | $58.96 | $337,985 | 125,397 (Direct) |
View |
| 2020-12-21 Sale |
2020-12-21 4:53 pm |
Stoke Therapeutics Inc. | STOK | Ticho Barry Chief Medical Officer |
1,365 | $57.62 | $78,654 | 257,802 (Direct) |
View |
| 2020-12-17 Sale |
2020-12-18 9:08 pm |
Stoke Therapeutics Inc. | STOK | Nash Huw M. COO & CBO |
50,000 | $60 | $3,000,000 | 352,757 (Direct) |
View |
| 2020-12-17 Sale |
2020-12-18 9:07 pm |
Stoke Therapeutics Inc. | STOK | Kaye Edward M. MD CEO |
25,000 | $60 | $1,500,000 | 0 (Direct) |
View |
| 2020-12-01 Sale |
2020-12-03 6:00 pm |
Stoke Therapeutics Inc. | STOK | Nash Huw M. COO & CBO |
5,700 | $49.84 | $284,080 | 131,097 (Direct) |
View |
| 2020-11-27 Sale |
2020-11-30 5:11 pm |
Stoke Therapeutics Inc. | STOK | Kaye Edward M. MD CEO |
12,152 | $50 | $607,600 | 25,000 (Direct) |
View |
| 2020-11-25 Sale |
2020-11-25 5:16 pm |
Stoke Therapeutics Inc. | STOK | Kaye Edward M. MD CEO |
12,848 | $50 | $642,400 | 37,152 (Direct) |
View |
| 2020-11-23 Sale |
2020-11-25 5:09 pm |
Stoke Therapeutics Inc. | STOK | TZIANABOS ARTHUR Director |
20,000 | $46.03 | $920,566 | 23,447 (Direct) |
View |
| 2020-11-24 Purchase |
2020-11-25 5:03 pm |
Stoke Therapeutics Inc. | STOK | Harrison Seth Loring Director 10% Owner |
375,000 | $39 | $14,625,000 | 17,161,713 (Indirect) |
View |
| 2020-11-24 Purchase |
2020-11-25 5:01 pm |
Stoke Therapeutics Inc. | STOK | Apple Tree Partners IV L.P. ATP III GP Ltd. 10% Owner |
375,000 | $39 | $14,625,000 | 17,161,713 (Direct) |
View |
| 2020-11-10 Sale |
2020-11-10 5:42 pm |
Stoke Therapeutics Inc. | STOK | Nash Huw M. COO & CBO |
50,000 | $45 | $2,250,000 | 359,168 (Direct) |
View |
| 2020-11-02 Sale |
2020-11-04 5:31 pm |
Stoke Therapeutics Inc. | STOK | Tulipano Stephen J CFO |
70,000 | $39 | $2,729,939 | 698,861 (Direct) |
View |
| 2020-11-02 Sale |
2020-11-04 5:30 pm |
Stoke Therapeutics Inc. | STOK | Nash Huw M. COO & CBO |
5,700 | $37.21 | $212,110 | 150,211 (Direct) |
View |
| 2020-10-16 Sale |
2020-10-20 4:52 pm |
Stoke Therapeutics Inc. | STOK | Liau Gene EVP Research & Preclinical Dev |
37,851 | $38.16 | $1,444,206 | 306,521 (Direct) |
View |
| 2020-10-13 Sale |
2020-10-13 5:43 pm |
Stoke Therapeutics Inc. | STOK | Liau Gene EVP Research & Preclinical Dev |
1,649 | $40 | $65,960 | 145,917 (Direct) |
View |
| 2020-10-01 Sale |
2020-10-05 5:12 pm |
Stoke Therapeutics Inc. | STOK | Nash Huw M. COO & CBO |
5,700 | $34.54 | $196,901 | 155,911 (Direct) |
View |
| 2020-09-08 Sale |
2020-09-10 6:21 pm |
Stoke Therapeutics Inc. | STOK | Nash Huw M. COO & CBO |
47,919 | $30 | $1,437,570 | 340,423 (Direct) |
View |
| 2020-09-01 Sale |
2020-09-03 6:35 pm |
Stoke Therapeutics Inc. | STOK | Nash Huw M. COO & CBO |
5,700 | $27.74 | $158,113 | 209,530 (Direct) |
View |
| 2020-08-28 Sale |
2020-08-31 6:04 pm |
Stoke Therapeutics Inc. | STOK | Nash Huw M. COO & CBO |
2,081 | $30 | $62,430 | 215,230 (Direct) |
View |
| 2020-08-03 Sale |
2020-08-04 4:59 pm |
Stoke Therapeutics Inc. | STOK | Nash Huw M. COO & CBO |
5,700 | $24.73 | $140,943 | 217,311 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
Ownership |
2021-06-30 4:14 pm |
N/A N/A |
Stoke Therapeutics Inc. | STOK | Skorpios Trust Blue Horizon Enterprise Ltd Ezbon International Ltd Montrago Trustees Ltd 10% Owner |
0 | $0 | 14,443,681 (Indirect) |
View |
| 2021-06-08 Option Award |
2021-06-25 5:04 pm |
N/A 2031-06-07 |
Stoke Therapeutics Inc. | STOK | TZIANABOS ARTHUR Director |
11,650 | $0 | 11,650 (Direct) |
View |
| 2021-06-08 Option Award |
2021-06-25 5:02 pm |
N/A 2031-06-07 |
Stoke Therapeutics Inc. | STOK | Smith Julie Director |
11,650 | $0 | 11,650 (Direct) |
View |
| 2021-06-08 Option Award |
2021-06-25 5:01 pm |
N/A 2031-06-07 |
Stoke Therapeutics Inc. | STOK | Menzel Garry E Director |
11,650 | $0 | 11,650 (Direct) |
View |
| 2021-06-08 Option Award |
2021-06-25 5:00 pm |
N/A 2031-06-07 |
Stoke Therapeutics Inc. | STOK | LEVIN ARTHUR A Director |
11,650 | $0 | 11,650 (Direct) |
View |
| 2021-06-08 Option Award |
2021-06-25 4:58 pm |
N/A 2031-06-07 |
Stoke Therapeutics Inc. | STOK | Krainer Adrian R. Director |
11,650 | $0 | 11,650 (Direct) |
View |
| 2021-06-08 Option Award |
2021-06-25 4:57 pm |
N/A 2031-06-07 |
Stoke Therapeutics Inc. | STOK | Harrison Seth Loring Director 10% Owner |
11,650 | $0 | 11,650 (Direct) |
View |
| 2021-06-08 Option Award |
2021-06-25 4:56 pm |
N/A 2031-06-07 |
Stoke Therapeutics Inc. | STOK | Burstein Jennifer Director |
11,650 | $0 | 11,650 (Direct) |
View |
| 2021-06-01 Exercise |
2021-06-03 5:48 pm |
N/A N/A |
Stoke Therapeutics Inc. | STOK | Nash Huw M. COO & CBO |
575 | $2.19 | 124,822 (Direct) |
View |
| 2021-06-01 Exercise |
2021-06-03 5:48 pm |
N/A 2028-12-12 |
Stoke Therapeutics Inc. | STOK | Nash Huw M. COO & CBO |
575 | $0 | 124,822 (Direct) |
View |
| 2021-03-02 Option Award |
2021-03-04 5:04 pm |
N/A 2031-03-01 |
Stoke Therapeutics Inc. | STOK | Tulipano Stephen J CFO |
65,600 | $0 | 65,600 (Direct) |
View |
| 2021-03-02 Option Award |
2021-03-04 5:03 pm |
N/A 2031-03-01 |
Stoke Therapeutics Inc. | STOK | Ticho Barry Chief Medical Officer |
65,600 | $0 | 239,231 (Direct) |
View |
| 2021-03-02 Option Award |
2021-03-04 5:01 pm |
N/A 2031-03-01 |
Stoke Therapeutics Inc. | STOK | Nash Huw M. COO & CBO |
65,600 | $0 | 65,600 (Direct) |
View |
| 2020-12-28 Exercise |
2021-03-04 5:00 pm |
N/A 2028-04-02 |
Stoke Therapeutics Inc. | STOK | Liau Gene EVP Research & Preclinical Dev |
13,195 | $0 | 233,094 (Direct) |
View |
| 2021-03-02 Option Award |
2021-03-04 5:00 pm |
N/A 2031-03-01 |
Stoke Therapeutics Inc. | STOK | Liau Gene EVP Research & Preclinical Dev |
40,800 | $0 | 233,094 (Direct) |
View |
| 2020-12-28 Exercise |
2021-03-04 5:00 pm |
N/A N/A |
Stoke Therapeutics Inc. | STOK | Liau Gene EVP Research & Preclinical Dev |
13,195 | $0.6 | 233,094 (Direct) |
View |
| 2021-03-02 Option Award |
2021-03-04 4:57 pm |
N/A 2031-03-01 |
Stoke Therapeutics Inc. | STOK | Kaye Edward M. MD CEO |
200,800 | $0 | 200,800 (Direct) |
View |
| 2021-03-01 Exercise |
2021-03-03 5:10 pm |
N/A 2026-02-11 |
Stoke Therapeutics Inc. | STOK | LEVIN ARTHUR A Director |
12,500 | $0 | 26,743 (Direct) |
View |
| 2021-03-01 Exercise |
2021-03-03 5:10 pm |
N/A N/A |
Stoke Therapeutics Inc. | STOK | LEVIN ARTHUR A Director |
4,618 | $0.4 | 26,743 (Direct) |
View |
| 2021-03-01 Exercise |
2021-03-03 5:10 pm |
N/A N/A |
Stoke Therapeutics Inc. | STOK | LEVIN ARTHUR A Director |
7,882 | $0.6 | 26,743 (Direct) |
View |
| 2021-02-22 Exercise |
2021-02-24 5:15 pm |
N/A N/A |
Stoke Therapeutics Inc. | STOK | Tulipano Stephen J CFO |
30,000 | $4.48 | 365,596 (Direct) |
View |
| 2021-02-22 Exercise |
2021-02-24 5:15 pm |
N/A 2029-03-18 |
Stoke Therapeutics Inc. | STOK | Tulipano Stephen J CFO |
30,000 | $0 | 365,596 (Direct) |
View |
| 2021-02-19 Exercise |
2021-02-23 5:28 pm |
N/A N/A |
Stoke Therapeutics Inc. | STOK | TZIANABOS ARTHUR Director |
10,000 | $2.19 | 13,447 (Direct) |
View |
| 2021-02-19 Exercise |
2021-02-23 5:28 pm |
N/A 2028-12-12 |
Stoke Therapeutics Inc. | STOK | TZIANABOS ARTHUR Director |
10,000 | $0 | 13,447 (Direct) |
View |
| 2020-08-13 Option Award |
2021-01-27 5:19 pm |
N/A 2030-08-13 |
Stoke Therapeutics Inc. | STOK | Menzel Garry E Director |
29,555 | $0 | 29,555 (Direct) |
View |
Ownership |
2021-01-27 5:17 pm |
N/A N/A |
Stoke Therapeutics Inc. | STOK | Menzel Garry E Director |
0 | $0 | 0 (Direct) |
View |
| 2021-01-04 Exercise |
2021-01-06 5:26 pm |
N/A N/A |
Stoke Therapeutics Inc. | STOK | Nash Huw M. COO & CBO |
5,700 | $2.19 | 125,397 (Direct) |
View |
| 2021-01-04 Exercise |
2021-01-06 5:26 pm |
N/A 2018-12-12 |
Stoke Therapeutics Inc. | STOK | Nash Huw M. COO & CBO |
5,700 | $0 | 125,397 (Direct) |
View |
| 2020-12-30 Exercise |
2021-01-04 6:33 pm |
N/A 2028-04-02 |
Stoke Therapeutics Inc. | STOK | Kaye Edward M. MD CEO |
10,000 | $0 | 647,801 (Direct) |
View |
| 2020-12-30 Exercise |
2021-01-04 6:33 pm |
N/A N/A |
Stoke Therapeutics Inc. | STOK | Kaye Edward M. MD CEO |
10,000 | $0.6 | 647,801 (Direct) |
View |
| 2020-12-21 Exercise |
2020-12-21 4:53 pm |
N/A N/A |
Stoke Therapeutics Inc. | STOK | Ticho Barry Chief Medical Officer |
1,365 | $2.19 | 257,802 (Direct) |
View |
| 2020-12-21 Exercise |
2020-12-21 4:53 pm |
N/A 2028-12-12 |
Stoke Therapeutics Inc. | STOK | Ticho Barry Chief Medical Officer |
1,365 | $0 | 257,802 (Direct) |
View |
| 2020-12-17 Exercise |
2020-12-18 9:08 pm |
N/A 2028-04-02 |
Stoke Therapeutics Inc. | STOK | Nash Huw M. COO & CBO |
50,000 | $0 | 352,757 (Direct) |
View |
| 2020-12-17 Exercise |
2020-12-18 9:08 pm |
N/A N/A |
Stoke Therapeutics Inc. | STOK | Nash Huw M. COO & CBO |
50,000 | $0.6 | 352,757 (Direct) |
View |
| 2020-12-01 Exercise |
2020-12-03 6:00 pm |
N/A N/A |
Stoke Therapeutics Inc. | STOK | Nash Huw M. COO & CBO |
5,700 | $2.19 | 131,097 (Direct) |
View |
| 2020-12-01 Exercise |
2020-12-03 6:00 pm |
N/A 2018-12-12 |
Stoke Therapeutics Inc. | STOK | Nash Huw M. COO & CBO |
5,700 | $0 | 131,097 (Direct) |
View |
| 2020-11-23 Exercise |
2020-11-25 5:09 pm |
N/A N/A |
Stoke Therapeutics Inc. | STOK | TZIANABOS ARTHUR Director |
20,000 | $2.19 | 23,447 (Direct) |
View |
| 2020-11-23 Exercise |
2020-11-25 5:09 pm |
N/A 2028-12-12 |
Stoke Therapeutics Inc. | STOK | TZIANABOS ARTHUR Director |
20,000 | $0 | 23,447 (Direct) |
View |
| 2020-11-10 Exercise |
2020-11-10 5:42 pm |
N/A N/A |
Stoke Therapeutics Inc. | STOK | Nash Huw M. COO & CBO |
13,414 | $2.19 | 359,168 (Direct) |
View |
| 2020-11-10 Exercise |
2020-11-10 5:42 pm |
N/A 2028-04-02 |
Stoke Therapeutics Inc. | STOK | Nash Huw M. COO & CBO |
50,000 | $0 | 359,168 (Direct) |
View |
| 2020-11-10 Exercise |
2020-11-10 5:42 pm |
N/A N/A |
Stoke Therapeutics Inc. | STOK | Nash Huw M. COO & CBO |
36,586 | $0.6 | 359,168 (Direct) |
View |
| 2020-11-02 Exercise |
2020-11-04 5:31 pm |
N/A N/A |
Stoke Therapeutics Inc. | STOK | Tulipano Stephen J CFO |
70,000 | $4.48 | 698,861 (Direct) |
View |
| 2020-11-02 Exercise |
2020-11-04 5:31 pm |
N/A 2029-03-18 |
Stoke Therapeutics Inc. | STOK | Tulipano Stephen J CFO |
70,000 | $0 | 698,861 (Direct) |
View |
| 2020-11-02 Exercise |
2020-11-04 5:30 pm |
N/A N/A |
Stoke Therapeutics Inc. | STOK | Nash Huw M. COO & CBO |
5,700 | $2.19 | 150,211 (Direct) |
View |
| 2020-11-02 Exercise |
2020-11-04 5:30 pm |
N/A 2018-12-12 |
Stoke Therapeutics Inc. | STOK | Nash Huw M. COO & CBO |
5,700 | $0 | 150,211 (Direct) |
View |
| 2020-10-19 Exercise |
2020-10-20 4:52 pm |
N/A N/A |
Stoke Therapeutics Inc. | STOK | Liau Gene EVP Research & Preclinical Dev |
1,503 | $2.19 | 306,521 (Direct) |
View |
| 2020-10-16 Exercise |
2020-10-20 4:52 pm |
N/A 2028-04-02 |
Stoke Therapeutics Inc. | STOK | Liau Gene EVP Research & Preclinical Dev |
37,851 | $0 | 306,521 (Direct) |
View |
| 2020-10-16 Exercise |
2020-10-20 4:52 pm |
N/A N/A |
Stoke Therapeutics Inc. | STOK | Liau Gene EVP Research & Preclinical Dev |
36,348 | $0.6 | 306,521 (Direct) |
View |
| 2020-10-13 Exercise |
2020-10-13 5:43 pm |
N/A 2028-04-02 |
Stoke Therapeutics Inc. | STOK | Liau Gene EVP Research & Preclinical Dev |
1,649 | $0 | 145,917 (Direct) |
View |
| 2020-10-13 Exercise |
2020-10-13 5:43 pm |
N/A N/A |
Stoke Therapeutics Inc. | STOK | Liau Gene EVP Research & Preclinical Dev |
1,649 | $0.6 | 145,917 (Direct) |
View |
| 2020-10-01 Exercise |
2020-10-05 5:12 pm |
N/A N/A |
Stoke Therapeutics Inc. | STOK | Nash Huw M. COO & CBO |
5,700 | $2.19 | 155,911 (Direct) |
View |
| 2020-10-01 Exercise |
2020-10-05 5:12 pm |
N/A 2018-12-12 |
Stoke Therapeutics Inc. | STOK | Nash Huw M. COO & CBO |
5,700 | $0 | 155,911 (Direct) |
View |
| 2020-09-08 Exercise |
2020-09-10 6:21 pm |
N/A N/A |
Stoke Therapeutics Inc. | STOK | Nash Huw M. COO & CBO |
47,919 | $2.19 | 340,423 (Direct) |
View |
| 2020-09-08 Exercise |
2020-09-10 6:21 pm |
N/A 2018-12-12 |
Stoke Therapeutics Inc. | STOK | Nash Huw M. COO & CBO |
47,919 | $0 | 340,423 (Direct) |
View |
| 2020-09-01 Exercise |
2020-09-03 6:35 pm |
N/A N/A |
Stoke Therapeutics Inc. | STOK | Nash Huw M. COO & CBO |
5,700 | $2.19 | 209,530 (Direct) |
View |
| 2020-09-01 Exercise |
2020-09-03 6:35 pm |
N/A 2018-12-12 |
Stoke Therapeutics Inc. | STOK | Nash Huw M. COO & CBO |
5,700 | $0 | 209,530 (Direct) |
View |
| 2020-08-28 Exercise |
2020-08-31 6:04 pm |
N/A N/A |
Stoke Therapeutics Inc. | STOK | Nash Huw M. COO & CBO |
2,081 | $2.19 | 215,230 (Direct) |
View |
| 2020-08-28 Exercise |
2020-08-31 6:04 pm |
N/A 2018-12-12 |
Stoke Therapeutics Inc. | STOK | Nash Huw M. COO & CBO |
2,081 | $0 | 215,230 (Direct) |
View |
| 2020-08-03 Exercise |
2020-08-04 4:59 pm |
N/A N/A |
Stoke Therapeutics Inc. | STOK | Nash Huw M. COO & CBO |
5,700 | $2.19 | 217,311 (Direct) |
View |
| 2020-08-03 Exercise |
2020-08-04 4:59 pm |
N/A 2018-12-12 |
Stoke Therapeutics Inc. | STOK | Nash Huw M. COO & CBO |
5,700 | $0 | 217,311 (Direct) |
View |